Portrazza – Necitumumab 800 mg/ 50 ml(16 mg/ ml) is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine, Bio-Similar and Innovator samples etc.
(Portrazza is registered trademarks Lilly USA)
What is PORTRAZZA:
PORTRAZZA is a medicine that contains the active substance Necitumumab and is available as single dose Vial.
In how many countries PORTRAZZA is approved for marketing:
PORTRAZZA is available/approved in USA and Europe. We can help you to access it in India.
What is PORTRAZZA used for:
PORTRAZZA is an epidermal growth factor receptor (EGFR) antagonist indicated, in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic squamous non-small cell lung cancer.
How can I get PORTRAZZA in India?
PORTRAZZA is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –firstname.lastname@example.org
We facilitate by –
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
PORTRAZZA can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin, and Pune other cities in India.
The Indian Pharma can facilitate the supply of PORTRAZZA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees.